The relevant clinical parameters, including CEA, CA19-9, tumor size, and white blood counts, in the diversity decreasing group (ΔChao1 < 0) and the diversity increasing group (ΔChao1 > 0) were compared. The gene discussed is CEACAM5; the disease is neoplasm.